ABVC BioPharma, Inc. (ABVC) vs IGC Pharma, Inc. (IGC)
- ABVC BioPharma, Inc. ABVC 0.92 −1.08%
- IGC Pharma, Inc. IGC 0.25 0.00%
ABVC BioPharma, Inc. and IGC Pharma, Inc. are both Biotechnology companies. ABVC BioPharma, Inc. and IGC Pharma, Inc. are of similar size ($26.3M and $24.9M). ABVC BioPharma, Inc. grew revenue faster over the last twelve months: 5,035.4% against −13.4%. ABVC BioPharma, Inc. has the higher net margin (0.00% vs −795.5%) and the higher return on invested capital (−33.5% vs −91.5%). Across the 18 metrics below, ABVC BioPharma, Inc. leads on 14 and IGC Pharma, Inc. on 4.
Valuation
Profitability
| Metric | ABVC | IGC | Biotechnology median |
|---|---|---|---|
| Gross margin | 99.97% | 32.33% | 65.16% |
| Operating margin | 0.00% | (912.44%) | 0.00% |
| Net margin | 0.00% | (795.46%) | 0.00% |
| Free cash flow margin | 0.00% | (516.53%) | 0.00% |
| Return on equity | (65.32%) | (143.46%) | (56.36%) |
| Return on assets | (39.88%) | (100.44%) | (48.04%) |
| Return on invested capital | (33.45%) | (91.53%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack